Discontinuation report GLYBURIDE
Report ID | 230704 |
Drug Identification Number | 02485664 |
Brand name | GLYBURIDE |
Common or Proper name | GLYBURIDE |
Company Name | PRO DOC LIMITEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GLYBURIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-12-31 |
Actual discontinuation date | 2024-06-17 |
Remaining supply date | 2025-04-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-06-27 | French | Compare |
v3 | 2024-06-27 | English | Compare |
v2 | 2024-06-17 | French | Compare |
v1 | 2024-06-17 | English | Compare |
Showing 1 to 4 of 4